Stay updated on TEPEZZA® Efficacy in Chronic Thyroid Eye Disease Clinical Trial

Sign up to get notified when there's something new on the TEPEZZA® Efficacy in Chronic Thyroid Eye Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TEPEZZA® Efficacy in Chronic Thyroid Eye Disease Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for TEPEZZA treatment in chronic (inactive) thyroid eye disease is now available, with study details, results-related information, locations, and data-sharing resources.
    Difference
    60%
    Check dated 2026-11-10T06:38:20.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T02:20:10.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide notice announces an NIH terminology transition, stating that “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-27T02:22:06.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2; the page continues to display a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-20T05:11:37.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T07:47:49.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record view. The added content shows the 403 header and related messaging, indicating restricted access to this page.
    Difference
    19%
    Check dated 2026-09-22T02:44:26.000Z thumbnail image

Stay in the know with updates to TEPEZZA® Efficacy in Chronic Thyroid Eye Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TEPEZZA® Efficacy in Chronic Thyroid Eye Disease Clinical Trial page.